top
Search terms
Results 1 - 4 of 4 - ordered by :
Ehjournal

Based on the analysis of adjusted mortality results of all 19 studies comprising 326 426 patients, digoxin use was associated with an increased relative risk of all-cause mortality [Hazard ratio (HR) ...

European Heart Journal, Vamos, Mate, Erath, Julia W., Hohnloser, Stefan H.

Date : 21/07/2015
Ehjournal

Aims X-VeRT is the first prospective randomized trial of a novel oral anticoagulant in patients with atrial fibrillation undergoing elective cardioversion. Methods and results We assigned 1504 ...

European Heart Journal, Cappato, Riccardo, Ezekowitz, Michael D., Klein, Allan L., Camm, A. John, Ma, Chang-Sheng, Le Heuzey, Jean-Yves, Talajic, Mario, Scanavacca, Maurício, Vardas, Panos E., ...

Date : 14/12/2014 Item size : 278462 bytes
Ehjournal

Abstract Aims X-VeRT is the first prospective randomized trial of a novel oral anticoagulant in patients with atrial fibrillation undergoing elective cardioversion. Methods and results We assigned ...

European Heart Journal, Cappato, Riccardo, Ezekowitz, Michael D., Klein, Allan L., Camm, A. John, Ma, Chang-Sheng, Le Heuzey, Jean-Yves, Talajic, Mario, Scanavacca, Maurício, Vardas, Panos E., ...

Date : 14/12/2014
Ehjournal

Based on the analysis of adjusted mortality results of all 19 studies comprising 326 426 patients, digoxin use was associated with an increased relative risk of all-cause mortality [Hazard ratio (HR) ...

European Heart Journal, Vamos, Mate, Erath, Julia W., Hohnloser, Stefan H.

Date : 21/07/2015 Item size : 4411 bytes